NT-proBNP、hs-CRP、LAD与慢性心力衰竭合并心房颤动的相关性

目的 分析N末端B型利钠肽前体(NT-proBNP)、超敏C反应蛋白(hs-CRP)、左心房内径(LAD)与慢性心力衰竭(CHF)合并心房颤动的相关性。方法 选取2019年9月-2020年9月在我院治疗的CHF患者287例,其中合并心房颤动患者91例为观察组,未合并心房颤动患者196例为对照组,分析两组一般资料、血糖、血脂、尿酸、肌酐、NT-proBNP、hs-CRP及超声心动图指标的差异,采用Logistic回归分析导致CHF患者发生心房颤动的危险因素。结果 观察组病程、NYHA分级为IV级患者比例、尿酸、肌酐、NT-proBNP、hs-CRP、LAD高于对照组(P<0.01)。Logistic分析显示,病程(OR=1.638)、心功能分级(OR=2.242)、NT-proBNP(OR=2.863)、hs-CRP(OR=2.341)、LAD(OR=3.671)是导致CHF合并心房颤动的主要影响因素(P<0.05)。结论 病程长、NYHA分级为IV级、NT-proBNP以及hs-CRP水平升高、LAD增大的CHF患者合并心房颤动的风险升高,对于存在上述危险因素的CHF患者应加强针对性干预,以减少心房颤动的发病。

Correlation between NT-proBNP,hs-CRP,left atrium diameter and chronic heart failure concurrent with atrial fibrillation

Objective To analyze the correlation between N-terminal pro-brain natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein (hs-CRP), left atrium diameter (LAD) and chronic heart failure (CHF) concurrent with atrial fibrillation. Methods A total of 287 CHF patients treated in our hospital from September 2019 to September 2020 were selected, 91 patients with atrial fibrillation were divided into the observation group and 196 patients without atrial fibrillation into in the control group. The difference of general information, blood glucose, blood lipid, uric acid, creatinine, NT-proBNP, hs-CRP and echocardiogram indexes in the two groups were analyzed, and the risk factors of CHF concurrent with atrial fibrillation were analyzed by Logistic regression. Results The course of disease, proportion of patients with New York Heart Association(NYHA) grade IV, uric acid, creatinine, NT-proBNP, hs-CRP, as well as LAD in the observation group were higher than in the control group(P<0.01). Logistic regression analysis showed that the course of disease (OR=1.638), cardiac function class (OR=2.242), NT-proBNP (OR=2.863), hs-CRP (OR=2.341), LAD(OR=3.671) were the main influencing factors of CHF concurrent with atrial fibrillation (P<0.05). Conclusion Long course of disease, IV in NYHA grade, the levels of NT-proBNP, hs-CRP and LAD increase added the risk of CHF concurrent with atrial fibrillation of patients. For CHF patients, targeted intervention should be strengthened to reduce the incidence of atrial fibrillation.